Exercise-Induced Release of Pharmacologically Active Substances and Their Relevance for Therapy of Hepatic Injury
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.3389/fphar.2016.00283
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2016
- Urheber
- DOI
-
10.18154/RWTH-CONV-210844
- URN
-
urn:nbn:de:101:1-2019082906163689768409
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:55 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schon, Hans-Theo
- Weiskirchen, Ralf
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2016
Ähnliche Objekte (12)
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Established Hepatic Stellate Cell Lines in Hepatology Research
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Insights in Gastrointestinal and hepatic pharmacology: 2021
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021
Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy
Weiskirchen, Ralf [Hrsg.] ; Friedman, Scott L. [Hrsg.]: Hepatic Stellate Cells. - New York, NY, 2023. - ISBN 978-1-07-163206-2; DOI: 10.1007/978-1-0716-3207-9
Cell therapy in liver fibrosis
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Established Hepatic Stellate Cell Lines in Hepatology Research
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Insights in Gastrointestinal and hepatic pharmacology: 2021
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021
Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy
Weiskirchen, Ralf [Hrsg.] ; Friedman, Scott L. [Hrsg.]: Hepatic Stellate Cells. - New York, NY, 2023. - ISBN 978-1-07-163206-2; DOI: 10.1007/978-1-0716-3207-9
Cell therapy in liver fibrosis
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Established Hepatic Stellate Cell Lines in Hepatology Research
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Insights in Gastrointestinal and hepatic pharmacology: 2021
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021
Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy
Weiskirchen, Ralf [Hrsg.] ; Friedman, Scott L. [Hrsg.]: Hepatic Stellate Cells. - New York, NY, 2023. - ISBN 978-1-07-163206-2; DOI: 10.1007/978-1-0716-3207-9